Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-24-000749
Filing Date
2024-09-10
Accepted
2024-09-10 16:12:57
Documents
2
Group Members
ORBIMED ROF II LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 12 ss3849381_sc13da.htm SC 13D/A 85312
2 JOINT FILING AGREEMENT ss3849381_ex9901.htm EX-99.1 4980
  Complete submission text file 0000947871-24-000749.txt   92078
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Subject) CIK: 0001453593 (see all company filings)

EIN.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86224 | Film No.: 241290220
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)